CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 130 enrolled / 130 target
Drug / intervention
BEST in CLASSbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04430010
NCT04430010N/ACompletedOn Track (2.3/mo)Completion was 2mo ago

Multi-level Determinants of Implementation and Sustainment in the Education Sector

Virginia Commonwealth University·interventional·Posted Jun 12, 2020·Updated Jun 2, 2026

In Brief

A clinical study evaluating BEST in CLASS for Evidence Based Programs in Schools. Completed, enrolled 130 participants across 2 sites.

Detailed Summary

The purpose of this study is to learn more about teachers' sustainment of use of core components of BEST in CLASS in a follow-up study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 12, 2020
Enrollment StartOct 1, 2021
Primary CompletionApr 30, 2026
TodayJul 2, 2026
Enrollment to primary: 4.6 yearsPosted 6.1 years ago

Arms & Interventions

Teacher Implementationexperimental

Teachers will implement the BEST in CLASS treatment in their classrooms. Teachers were trained and coached in delivering the intervention during their participation in the prior efficacy trial. In the school year of the present study, the teacher implements the intervention without further support from a coach.

Behavioral: BEST in CLASS
Focal Studentexperimental

One to three students within a participating teacher's classroom are nominated by the teacher and screened for elevated risk of emotional behavior challenges. The teacher delivers the BEST in CLASS intervention to the focal child(ren) in their classroom.

Behavioral: BEST in CLASS

Interventions

BEST in CLASSbehavioral

BEST in CLASS is a Tier-2 evidence based program (EBP) that has demonstrated effectiveness at reducing children's Disruptive Behavior Problems (DBPs) and risk for Emotional and Behavioral Disorders (EBDs).